Orange Book product · Brand (NDA)
BELEODAQ
BELINOSTAT
Brand (NDA)NDA 206256RX ACROTECH BIOPHARMA
At a glance
Jul 03, 2014
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 03, 2014
12 yr 2 mo ago
Today
Patent 6888027 expires
Listed drug substance patent expiration.
Aug 10, 2026
in 2 mo
Patent 8835501 expires
Listed drug product patent expiration.
Oct 27, 2027
in 1 yr 5 mo
Pharmaceutical detail
Active ingredient
BELINOSTAT
Strength
500MG/VIAL
Dosage form
POWDER
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 206256
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 6888027 | Aug 10, 2026 | in 2 mo | SubstanceProductU-1544 |
| 8835501 | Oct 27, 2027 | in 1 yr 5 mo | Product |
